Pfizer Inc. (PFE)
Pfizer Jumps After Activist Investor Starboard Reportedly Takes $1 Billion Stake
Pfizer stock popped Monday on a report activist investor Starboard Value took a roughly $1 billion stake in the struggling drugmaker.
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Starboard Value's $1 Billion Stake Boosts Pfizer (PFE) Shares
Media reports indicate that activist investor Starboard Value has acquired approximately $1 billion worth of shares in Pfizer (PFE, Financial). Following this news, Pfizer's stock rose nearly 3% in pre-market trading.
4 Reasons Pfizer Could Be a Value Play You Can't Miss
Pfizer Inc. NYSE: PFE hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE NASDAQ: BNTX sent shares surging up to $61.71 in December 2021, driven by its COVID-19 vaccine sales. Since then, it's been downhill for the medical sector giant as COVID revenues dried up with the pandemic in the rearview mirror.
Starboard's stake in Pfizer 'doesn't make any sense to me at all', says Dartmouth's Paul Argenti
Paul Argenti, Dartmouth Tuck School of Business professor, joins 'Squawk Box' to discuss news of activist investor Starboard Value amassing a roughly $1 billion stake in drugmaker Pfizer, whether Pfizer makes sense as an activist target, and more.
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Pfizer Inc. PFE may have been a hero in the COVID-19 vaccine race, but its stock is stuck in the slow lane. Down nearly 14% over the last year, the pharma giant's shares have struggled as demand for its pandemic-related treatments has fizzled out.
Pfizer Stock Rises on Report Starboard Takes Roughly $1B Stake
Shares of Pfizer (PFE) are rising in premarket trading Monday following a report that activist investor Starboard Value has taken a roughly $1 billion stake in the struggling drugmaker.
Pfizer wins bid to invalidate GSK's patents over RSV vaccine
Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus (RSV) vaccine.
Activist Investor Starboard Value Take $1 Billion Stake in Pfizer
Activist investor Starboard Value is seeking to spur a turnaround of Pfizer, taking a stake of about $1 billion in the struggling pharmaceuticals giant, according to a person familiar with the matter. Charlie Wells reports on Bloomberg Television.
Pfizer Has an Activist. Pharma Giant Is Latest Target of Starboard.
Activist investor Starboard Value has reportedly amassed a $1 billion stake in Pfizer.
Starboard Value's $1 billion move: will Pfizer see a much-needed revival?
In a bid to reshape Pfizer's future, activist investor Starboard Value has acquired a stake worth approximately $1 billion, according to reports. The move comes as the pharmaceutical giant faces mounting challenges, including declining demand for its Covid-19 products and increased competition.
Pfizer: Activist investor Starboard Value takes $1bn stake
Activist investor Starboard Value has acquired a $1 billion stake in Pfizer Inc (NYSE:PFE, ETR:PFE) and is pushing for changes at the pharmaceutical giant, according to the Wall Street Journal. While Starboard's specific plans remain unclear, it has reportedly engaged with former Pfizer executives Ian Read and Frank D'Amelio to support its efforts.
